Literature DB >> 7925955

Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma.

J Sakata1, T Shimokubo, K Kitamura, M Nishizono, Y Iehiki, K Kangawa, H Matsuo, T Eto.   

Abstract

Adrenomedullin is a new bioactive peptide recently isolated from pheochromocytoma. We report on the rat adrenomedullin distribution and molecular forms in various tissues and plasma. Using a sensitive radioimmunoassay system for rat adrenomedullin, high concentrations of immunoreactive rat adrenomedullin were detected in adrenal gland, lung and cardiac atrium. In lung and atrium, the immunoreactivity concentration in rat was about 6-10 times higher than that in human. The mean plasma concentration of immunoreactive rat adrenomedullin was 3.60 +/- 0.34 fmol/ml (mean +/- S.D.). Analysis in adrenal gland, lung and atrium with reverse-phase and gel-filtration high-performance liquid chromatography showed that most immunoreactive rat adrenomedullin emerged as a single peak at a position exactly identical to that of the authentic rat adrenomedullin peptide, synthesized according to the sequence predicted from the cDNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925955     DOI: 10.1016/0014-5793(94)00928-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  Adrenomedullin. Implications for hypertension research.

Authors:  K Kitamura; K Kangawa; H Matsuo; T Eto
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

2.  Adrenomedullin increases fluid extravasation from the splenic circulation of the rat.

Authors:  S Kaufman; P Andrew; R Sultanian; Y Deng
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

3.  Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension.

Authors:  N Nagaya; T Nishikimi; M Uematsu; T Satoh; H Oya; S Kyotani; F Sakamaki; K Ueno; N Nakanishi; K Miyatake; K Kangawa
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

4.  Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.

Authors:  L'Houcine Ouafik; Samantha Sauze; Françoise Boudouresque; Olivier Chinot; Christine Delfino; Frédéric Fina; Vincent Vuaroqueaux; Christophe Dussert; Jacqueline Palmari; Henri Dufour; François Grisoli; Pierre Casellas; Nils Brünner; Pierre-Marie Martin
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

5.  Local regulator adrenomedullin contributes to the circulatory disturbance in cirrhotic rats.

Authors:  Shinya Sakurai; Hideyuki Kojima; Masahito Uemura; Hiroyasu Satoh; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

6.  Coexpression of adrenomedullin and its receptor component proteins in the reproductive system of the rat during gestation.

Authors:  Lei Li; Fai Tang; Wai-Sum O
Journal:  Reprod Biol Endocrinol       Date:  2010-10-29       Impact factor: 5.211

Review 7.  Adrenomedullin, a Novel Target for Neurodegenerative Diseases.

Authors:  Hilda Ferrero; Ignacio M Larrayoz; Francisco J Gil-Bea; Alfredo Martínez; María J Ramírez
Journal:  Mol Neurobiol       Date:  2018-03-29       Impact factor: 5.590

8.  Adrenomedullin in rat follicles and corpora lutea: expression, functions and interaction with endothelin-1.

Authors:  Lei Li; Wai-Sum O; Fai Tang
Journal:  Reprod Biol Endocrinol       Date:  2011-08-09       Impact factor: 5.211

9.  Proadrenomedullin N-terminal 20 peptide inhibits adrenocorticotropin secretion from cultured pituitary cells, possibly via activation of a potassium channel.

Authors:  W K Samson; T C Murphy; Z T Resch
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

Review 10.  Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3.

Authors:  D van Lier; M Kox; P Pickkers
Journal:  J Intern Med       Date:  2020-12-30       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.